HomeCompareMIRO vs EQR

MIRO vs EQR: Dividend Comparison 2026

MIRO yields 59.00% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MIRO wins by $572.4K in total portfolio value
10 years
MIRO
MIRO
● Live price
59.00%
Share price
$3.39
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$620.2K
Annual income
$143,088.77
Full MIRO calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — MIRO vs EQR

📍 MIRO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMIROEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MIRO + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MIRO pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MIRO
Annual income on $10K today (after 15% tax)
$5,014.75/yr
After 10yr DRIP, annual income (after tax)
$121,625.45/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, MIRO beats the other by $116,971.19/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MIRO + EQR for your $10,000?

MIRO: 50%EQR: 50%
100% EQR50/50100% MIRO
Portfolio after 10yr
$334.0K
Annual income
$74,282.18/yr
Blended yield
22.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

MIRO
Analyst Ratings
2
Buy
Consensus: Buy
Price Target
$9.00
+165.5% upside vs current
Range: $9.00 — $9.00
Altman Z
-3.6
Piotroski
3/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MIRO buys
0
EQR buys
0
No recent congressional trades found for MIRO or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMIROEQR
Forward yield59.00%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8%
Portfolio after 10y$620.2K$47.8K
Annual income after 10y$143,088.77$5,475.61
Total dividends collected$512.6K$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyHold
Analyst price target$9.00$70.35

Year-by-year: MIRO vs EQR ($10,000, DRIP)

YearMIRO PortfolioMIRO Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$16,600$5,899.71$11,380$679.82+$5.2KMIRO
2$26,914$9,152.65$13,014$837.25+$13.9KMIRO
3$42,667$13,869.04$14,961$1,036.20+$27.7KMIRO
4$66,202$20,548.25$17,297$1,289.22+$48.9KMIRO
5$100,633$29,796.73$20,121$1,613.15+$80.5KMIRO
6$150,008$42,330.45$23,561$2,030.84+$126.4KMIRO
7$219,480$58,971.49$27,783$2,573.54+$191.7KMIRO
8$315,482$80,637.85$33,013$3,284.39+$282.5KMIRO
9$445,892$108,326.32$39,547$4,223.51+$406.3KMIRO
10$620,193$143,088.77$47,791$5,475.61+$572.4KMIRO

MIRO vs EQR: Complete Analysis 2026

MIROStock

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

Full MIRO Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this MIRO vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MIRO vs SCHDMIRO vs JEPIMIRO vs OMIRO vs KOMIRO vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.